According to a market report by Lucintel, the future of the metastatic colorectal cancer market in United States looks promising with opportunities in the hospital, cancer center, and ambulatory surgical center markets. The metastatic colorectal cancer market in United States is expected to grow with a CAGR of 4.3% from 2025 to 2031. The major drivers for this market are the growing FDA approval for the treatment of metastatic colorectal cancer and a rise in research projects.
A more than 150-page report to understand trends, opportunity and forecast in metastatic colorectal cancer market in United States to 2031 by treatment (chemotherapy, targeted therapies, immunotherapies, monotherapy & combination therapy, and others), drug class (anti-EGFR inhibitors, anti-VEGF therapies, anti-HER2 therapies, immune checkpoint inhibitors, and others), and end use (hospitals, cancer centers, ambulatory surgical centers, and others).
Download sample by clicking on metastatic colorectal cancer market in United States
Lucintel forecasts that, within the treatment category, chemotherapy is expected to witness the largest growth over the forecast period.
Within the end use category, the hospital is expected to witness the highest growth.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Metastatic Colorectal Cancer Market in Australia
Metastatic Colorectal Cancer Market in Brazil
Metastatic Colorectal Cancer Market in Canada
Metastatic Colorectal Cancer Market in Mexico
Metastatic Colorectal Cancer Market in Saudi Arabia
Metastatic Colorectal Cancer Market in South Africa